Biomarkers

BIOMARKERS

Hormone assays are essential tests for the diagnosis, treatment, and prevention of certain chronic diseases such as diabetes and osteoporosis. According to the Partnership for the Accurate Testing of Hormones (PATH), when two laboratories use different tests to measure a hormone level, they may get different results for the same patient even though they use the same sample. These inaccurate test results can lead to a misdiagnosis and/or a delayed or incorrect treatment.


Contact Leslie Best to learn more about NACDD’s work on laboratory standardization and biomarkers.

NACDD Action on Biomarkers


NACDD collaborates with CDC, the Endocrine Society, and PATH in a partnership to improve the quality of laboratory measurements for chronic disease biomarkers. The strategic plan advocates for the universal adoption of accuracy-based testing in medical practice and research to advance the development of standardized chronic disease biomarker tests. As a result, NACDD has created a detailed brochure explaining how clinical standardization can improve the diagnosis, detection, and treatment of chronic diseases.


NACDD has also worked with CDC’s Division of Laboratory Sciences and its National Center for Environmental Health to manage and co-chair the Cardiovascular Biomarker Standardization Steering Committee and develop translation documents in response to the first and second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population. The biochemical indicators reports provide reference intervals for selected nutritional indicators in the U.S. population, and our translation responses help to integrate the findings into public health practice for prevention and control of chronic disease.



National Association of Chronic Disease Directors
325 Swanton Way
Decatur, GA 30030
info@chronicdisease.org
Hours of Operation: Mon. - Fri., 8 a.m. - 4:30 p.m.